Novo Nordisk A/S
Ceasefire extension, Best Buy’s new CEO, Amazon’s GLP-1 push and more in Morning Squawk
This is CNBC’s Morning Squawk newsletter. Subscribe here to receive future editions in your inbox. Happy Wednesday. With all the volatility in the oil market, I found it helpful to look at this timeline for a reminder of all that’s happened over the last eight weeks. Stock futures are higher this morning. All three major indexes closed […]
Read More
Amazon launches GLP-1 weight loss program, promising ‘fast, convenient’ access
Amazon GLP-1 treatment Source: Amazon Inc. Amazon is pushing deeper into the booming weight loss market, unveiling Tuesday a new program that aims to simplify access to popular GLP-1 treatments. The company said its primary care arm, Amazon One Medical, is launching a GLP-1 management program that integrates obesity treatment into routine care. The offering […]
Read More
Nearly 60% of U.S. farmers say their finances are getting worse as fertilizer, fuel costs rise: Survey
Fertilizer is spread across a field in China Grove, North Carolina, on April 10, 2026. Grant Baldwin | AFP | Getty Images On a farm in Goldsboro, North Carolina, where her husband’s family has worked the land for generations, Lorenda Overman is facing familiar hurdles — but also new pressures she couldn’t have predicted only […]
Read More
Stocks making the biggest moves premarket: Novo Nordisk, JPMorgan Chase, United Airlines & more
Check out the companies making the biggest moves premarket: Novo Nordisk — U.S.-listed shares popped 3% after the company announced a partnership with OpenAI . “Integrating AI in our everyday work gives us the ability to analyse datasets at a scale that was previously impossible, identify patterns we could not see, and test hypotheses faster […]
Read More
Novo Nordisk partners with OpenAI as AI drug discovery hopes mount
People walk past a sign for Novo Nordisk’s annual general meeting at the entrance to the venue in Copenhagen, Denmark, March 26, 2026. Tom Little | Reuters Novo Nordisk is partnering with OpenAI to “bring new and better treatment options to patients faster,” the Danish drugmaker said Tuesday. The partnership will enable Novo to better […]
Read More
Eli Lilly market share drops, Novo Nordisk holds firm as generic weight-loss drugs flood India
The Eli Lilly and Novo Nordisk logos. Mike Blake | Tom Little | Reuters The market share of India’s most popular weight‑loss drugmaker, Eli Lilly, slipped in March, while rival Novo Nordisk held steady even as Indian generic drugmakers flooded the market with lower‑priced copies. Eli Lilly’s Indian market share in the GLP‑1 category of […]
Read More
As millions lose weight on GLP-1s, they’re starting to turn to retailers to refresh their wardrobes
Michelle Suter has worn mostly big and baggy clothing for years. The 63-year-old retiree who lives in a suburb of St. Louis, Missouri gave away her favorite sundresses and other form-fitting outfits, thinking she’d never be those smaller sizes again. Now, after losing about 28 pounds while taking GLP-1 drug Wegovy, she said she has […]
Read More